Reports

2026, week 29: the deadliness of pleural mesothelioma, what we've been doing to stop his disease, and the first successes of regression.

4 months of treatment with a pharmaceutical plan formulated to suppress IL-6 over-expression in one patient has shown first success. Continuation and reproducibility of the effect remain to be seen.

The goal of making grainless Laugengebäck is yet at distance, though significant strides have been made in the mouthfeel and taste of the bread.

Most people in the world like or even love eating bread. I want to engineer a similar tasting bread having the benefit, however, of being grainless.

The second part of the story of our dad fighting, and apparently winning the war on cancer.

The first part of the story of our dad fighting, and apparently winning the war on cancer.